Pharmaceutical Executive-12-01-2012

The Puzzle Master

Tax and budget decisions will shape the healthcare market and drug research and regulation.

At two years and counting, what's the secret of success in negotiating pricing under the new AMNOG legislation?

Eli Lilly's pioneering pact with leading CRO Covance made big news when it happened. Four years later, both parties can point to metrics that suggest the benefit is mutual.

Europe's chief regulator charts a strategy from many moving parts. Dr Guido Rasi talks to Pharm Exec's William Looney.

Ben Comer profiles 10 innovative technologies designated as new and revolutionary tools for the treatment of disease and disability.